Difference between revisions of "Resource:69dad1bb-9632-43ed-b3c1-c49a1fcd8910"
From The Embassy of Good Science
| Line 1: | Line 1: | ||
{{Resource | {{Resource | ||
|Resource Type=Cases | |Resource Type=Cases | ||
| − | |Title= | + | |Title=Industry involvement in scientific studies on SSRI's |
| − | |Is About=This case is about scientific fraud in research concerning psychopharmacology. Specifically, it is about the use of the selective serotonin reuptake inhibitor (SSRI) group of antidepressants that has the potential to trigger suicidality in a subgroup of patients. This is a factual case, linked to | + | |Is About=This case is about scientific fraud in research concerning psychopharmacology. Specifically, it is about the use of the selective serotonin reuptake inhibitor (SSRI) group of antidepressants that has the potential to trigger suicidality in a subgroup of patients. This is a factual case, linked to companies' abilties to keep clinical trial data out of the public domain. |
|Important Because=The outcome of such research affects the lives of many patiens who use the SSRI's. | |Important Because=The outcome of such research affects the lives of many patiens who use the SSRI's. | ||
|Important For=Researchers; research integrity researchers; Early career researchers; Ethics committee members | |Important For=Researchers; research integrity researchers; Early career researchers; Ethics committee members | ||
Revision as of 21:12, 22 October 2020
ResourcesCases
Industry involvement in scientific studies on SSRI's
What is this about?
This case is about scientific fraud in research concerning psychopharmacology. Specifically, it is about the use of the selective serotonin reuptake inhibitor (SSRI) group of antidepressants that has the potential to trigger suicidality in a subgroup of patients. This is a factual case, linked to companies' abilties to keep clinical trial data out of the public domain.
Why is this important?
The outcome of such research affects the lives of many patiens who use the SSRI's.
